Michele Johnson, left, and Andrew Clubok, right, with Latham & Watkins.

Latham & Watkins

Tell us about your biggest trial win from January 2018 through June 2019 and how you achieved the result for your client.

We achieved a company-saving result for breast-cancer treatment developer Puma Biotechnology, marking the first federal securities class action to reach a verdict in nearly a decade. Plaintiff sought damages exceeding $1.2 billion against Puma, which, at the time of trial, had a market cap of $1 billion. The jury delivered a unanimous verdict in Puma's favor on three of the four alleged misstatements, and awarded less than 5% of claimed damages (estimated to be $9 million or less after a lengthy claims process). Our near-complete win preserved the company's ability to deliver lifesaving cancer treatments to patients who would otherwise be out of options under the standard of care before Puma.

Share two trial tips that have been key to your success.

1) Thoroughly prepare your witnesses, then prepare them again, not just on the substance of their testimony, expected cross-examination, and trial themes but also on demeanor, tone and helpfulness to the jury.

2) Empower and deploy a diverse trial team with true substantive responsibilities. No tokens allowed